your market intelligence analyst
Search Results
366 results
Your search is now limited to «Liver Cancer» expert search.
Business Wire 07/18/2019 11:45
STRASBOURG, France--(BUSINESS WIRE)-- $TNG #OncolyticVirus --Regulatory News: Transgene (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of solid tumors, today announces it has received the approval from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) to proceed with a Phase 1/2a clinical trial of TG6002 administered by intrahepatic artery (IHA) infusion in colorectal cancer patients with unresectable liver metastases (CRLM).
More from Business Wire:
Natural Health 365 07/18/2019 01:11
The most definite link found was with the most common type of liver cancerhepatocellular carcinoma.
More from Natural Health 365:
In vitro chemotaxis analysis indicated that HCC cells overexpressing IL-37 recruited more DCs by secreting higher levels of specific chemokines (eg, CCL3 and CCL20.
More from International Journal of COPD: 07/17/2019 12:32
After considering other risk factors for liver cancer, the researchers found that those who consumed the most whole grains had as much as 37 percent lower risk of liver cancer than those who consumed the least.
More from
PR Newswire 07/17/2019 09:10
Characterized by inflammation and fibrosis, NASH can progress asymptomatically to more serious disease stages, including advanced liver fibrosis, cirrhosis, and cancer.
More from PR Newswire: 07/17/2019 07:53
This trial studies how well an investigational scan (magnetic resonance elastography [MRE]) works with standard imaging (magnetic resonance imaging [MRI]) in detecting response to treatment in patients with liver cancer that has spread to other places in the body.
More from
ecancer news 07/16/2019 05:21
We also found that the IL-6/JAK1 pathway contributed to PD-L1 phosphorylation, which appeared to be the dominant driver of cancer immune evasion in a liver cancer mouse model," said Chan.
More from ecancer news:
FeedNavigator (EU) 07/12/2019 13:07
NAFLD covers a spectrum that ranges from simple steatosis, nonalcoholic steatohepatitis (NASH) with varying degrees of fibrosis, to cirrhosis, which is a major risk factor for hepatocellular carcinoma.
More from FeedNavigator (EU):
Cancer Cell International 07/11/2019 20:00
Moreover, the blockade of YAP endowed HCC with sensitivity to chemotherapeutic agents.
More from Cancer Cell International:
Targeted Oncology 07/11/2019 17:00
For somebody like this, I would say her liver looks like there is hepatocellular carcinoma [HCC], so we do not need to biopsy that.
More from Targeted Oncology:
PubMed News (NIH) 07/10/2019
Liver cancer stem cells (CSCs) may account for a hierarchical organization of heterogeneous cancer cells.
More from PubMed News (NIH):
At the time of designation, hepatocellular carcinoma affected approximately 1 in 10,000 people in the European Union (EU.
More from European Medicines Agency - EMEA (EU):
Resectability of Tumor Experienced surgeons resected tumors in patients with hepatocellular carcinoma (HCC) and portal vein tumor thrombus (PVTT.
More from American Society of Clinical Oncolgy (ASCO):
Healio News 07/04/2019 08:00
Race-matched liver transplants improve survival for black patients with hepatocellular carcinoma Race-matched liver transplants significantly improved overall survival among black patients with early hepatocellular carcinoma, according to study results published in Journal of the American College of Surgeons ...
More from Healio News:
Patients with A1AT deficiency are also at risk for developing hepatocellular carcinoma.
More from Pharmaceutical Business Review:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications